Author: foodpoisoningnews

[ad_1] Reflecting its uncompromising commitment to patient safety, Alcon now announced a direct, voluntary market withdrawal of their CyPass Micro-Stent in the worldwide industry. Additionally, Alcon advises surgeons to quickly cease additional implantation using the CyPass Micro-Stent and to return any unused devices to Alcon. This conclusion and corresponding recommendation is based on an investigation of post-surgery data in the COMPASS-XT long-term security analysis. The US Food and Drug Administration (FDA) accepted the CyPass Micro-Stent at July 2016 for use in combination with cataract surgery in older patients using mild-to-moderate main open-angle glaucoma dependent on the outcomes of the landmark…

Read More